Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial | |
Yuan, Jinyi; Mo, Biwen; Ma, Zhuang; Lv, Yuan; Cheng, Shih-Lung; Yang, Yanping; Tong, Zhaohui; Wu, Renguang; Sun, Shenghua; Cao, Zhaolong | |
刊名 | JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION |
2019 | |
卷号 | 52期号:1 |
关键词 | Clinical outcome Community-acquired pneumonia Levofloxacin Nemonoxacin Randomized controlled trial Safety |
ISSN号 | 1684-1182 |
DOI | 10.1016/j.jmii.2017.07.011 |
URL标识 | 查看原文 |
收录类别 | SCIE |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4264004 |
专题 | 武汉大学 |
推荐引用方式 GB/T 7714 | Yuan, Jinyi,Mo, Biwen,Ma, Zhuang,et al. Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial[J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2019,52(1). |
APA | Yuan, Jinyi.,Mo, Biwen.,Ma, Zhuang.,Lv, Yuan.,Cheng, Shih-Lung.,...&Su, Wei-Juin.(2019).Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial.JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,52(1). |
MLA | Yuan, Jinyi,et al."Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial".JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION 52.1(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论